SCHEMBL5603642

SCHEMBL5603642

[CH]1CCC[C@@H]2CC=CC=C12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1446243 0.87
SCHEMBL12521070 0.82
SCHEMBL4429690 0.72
SCHEMBL3602257 0.68
SCHEMBL6507628 0.68
SCHEMBL3809774 0.67
SCHEMBL3813203 0.67
SCHEMBL22038 0.65
SCHEMBL30286384 0.64
SCHEMBL28730248 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007096753-A2 PROCESS FOR PREPARING HIGHLY PURE SIMVASTATIN CADILA HEALTHCARE LIMITED (IN) 2007-08-30 WO disclosed
WO-2005077928-A1 IMPROVED PROCESS FOR PRODUCING SIMVASTATIN JUBILANT ORGANOSYS LIMITED (IN) 2005-08-25 WO disclosed
EP-1463723-A4 PROCESS FOR THE PREPARATION OF SIMVASTATIN HANMI PHARM IND CO LTD (KR) 2005-04-27 EP disclosed
EP-1463723-A1 PROCESS FOR THE PREPARATION OF SIMVASTATIN Hanmi Pharm. Co., Ltd. (KR) 2004-10-06 EP disclosed
WO-2003057684-A1 PROCESS FOR THE PREPARATION OF SIMVASTATIN HANMI PHARM. CO., LTD. (KR) 2003-07-17 WO disclosed